• Profile
Close

Type 2 diabetes mellitus is a risk factor for progression of liver fibrosis in middle-aged patients with nonalcoholic fatty liver disease

Journal of Gastroenterology and Hepatology May 25, 2019

Tada T, et al. - In over 1,500 middle-aged (36–64 years) patients with nonalcoholic fatty liver disease (NAFLD) and less severe live fibrosis (FIB-4 index < 1.3), researchers assessed clinical risk factors for the progression of liver fibrosis. A total of 186 patients progressed to advanced fibrosis (FIB-4 index > 2.67) during follow-up. The investigators noted that the 3-, 5-, 7-, and 10-year cumulative incidences of progression to advanced fibrosis were 4.4%, 6.7%, 11.0%, and 16.7%, respectively. In middle-aged patients with NAFLD, even those with less severe liver fibrosis, type 2 diabetes mellitus was linked to progression to advanced liver fibrosis.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay